HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial von CALMY, Alexandra, GAYET-AGERON, Angèle, ANANWORANICH, Jintanat, MONTECUCCO, Fabrizio, NGUYEN, Alain, MACH, Francois, BURGER, Fabienne, UBOLYAM, Sasiwimol, CARR, Andrew, RUXUNGTHAM, Kiat, HIRSCHEL, Bernard

Volltext

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection von NÜESCH, Reto, ANANWORANICH, Jintanat, SRASUEBKUL, Preeyaporn, CHETCHOTISAKD, Ploenchan, PRASITHSIRIKUL, Wisit, KLINBUAYAM, Wirat, MAHANONTHARIT, Apicha, JUPIMAI, Thidarat, RUXRUNGTHAM, Kiat, HIRSCHEL, Bernard

Volltext

Ferritin levels during structured treatment interruption of highly active antiretroviral therapy von Boom, J, Kösters, E, Duncombe, C, Kerr, S, Hirschel, B, Ruxrungtham, K, De Mast, Q, Kosalaraksa, P, Ulbolyam, S, Jupimai, T, Ananworanich, J

Volltext

Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure von Langford, Simone, Gayet-Ageron, Angele, Duncombe, Chris, Jupimai, Thidarat, Mahanontharit, Apicha, Kiertiburanakul, Sasisopin, Munsakul, Warangkana, Ruxrungtham, Kiat, Hirschel, Bernard, Ananworanich, Jintanat

Volltext